BWA
48
-4
MCO
70
3
FCX
40
-2
EXR
57
9
AKAM
43
-2
ILMN
41
10
HOG
39
-3
NTAP
53
4
JNJ
62
2
CCI
36
13
KO
55
-12
ACN
47
14
CA
43
-6
EIX
35
-13
EXPD
29
2
AMT
55
3
COP
33
-6
FE
67
-3
CHD
48
3
MDLZ
71
8
BWA
48
-4
MCO
70
3
FCX
40
-2
EXR
57
9
AKAM
43
-2
ILMN
41
10
HOG
39
-3
NTAP
53
4
JNJ
62
2
CCI
36
13
KO
55
-12
ACN
47
14
CA
43
-6
EIX
35
-13
EXPD
29
2
AMT
55
3
COP
33
-6
FE
67
-3
CHD
48
3
MDLZ
71
8
Financhill
Back

Salesforce 10K Form

Sell
49

CRM
Salesforce

Last Price:
$268.34
Seasonality Move:
5.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CRM News And Ratings

See the #1 stock for the next 7 days that we like better than CRM

CRM Financial Statistics

Sales & Book Value

Annual Sales: $37.9B
Cash Flow: $3.8B
Price / Cash Flow: 21.04
Annual Sales: $63.59
Price / Book: 4.22

Profitability

EPS (TTM): 6.36000
Net Income (TTM): $6.2B
Gross Margin: $29.3B
Return on Equity: 10.45%
Return on Assets: 6.42%

Salesforce Earnings Forecast

Key Salesforce Financial Ratios

  • The Gross Profit Margin over the past 25 years for CRM is 77.19%.
  • The Selling, General & Administrative Expenses for CRM have been equal to 42.47% of Gross Profit Margin.
  • The Research & Development expenses have been 14.50% of Revenue.
  • The Interest Expense is 13.87% of Operating Income.
  • The Net Earning history of CRM is 16.35% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 16 years.

Salesforce Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Software
Sector: Information Technology
Current Symbol: CRM
CUSIP: 79466L
Website: salesforce.com

Debt

Debt-to-Equity Ratio: 0.14
Current Ratio: 1.06
Quick Ratio: 0.93

Price-to-Earnings

Trailing P/E Ratio: 42.25
Forward P/E Ratio: 21.43

CRM Technical Analysis vs Fundamental Analysis

Sell
49
Salesforce (CRM) is a Sell

Is Salesforce a Buy or a Sell?

  • Salesforce stock is rated a Sell
    The current Salesforce [CRM] share price is $268.71. The Score for CRM is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.